Our Board Of Advisers


Dr. Mark Bouzyk

Dr. Bouzyk was a Director of the Emory Biomarker Service Center (EBSC), Director, Basic Research Shared Core Resources, Emory Winship Cancer Institute, Emory University as well as Director of the Center for Medical Genomics at Emory University, Atlanta. These facilities were developed by Dr. Bouzyk as state of the art laboratory capabilities to enable high throughput genetic, genomic and microarray biomarker studies ranging from DNA, copy number variation, expression, miRNA and methylation profiling all supported by a robust and flexible data management infrastructure in a Clinical Laboratory Improvement Amendments (CLIA) environment.

Prior to joining Emory, Dr. Bouzyk spent approximately 9 years in a global pharmaceutical company, GlaxoSmithKline, where he served as Director of Genetic Laboratory Sciences leading the company’s high throughput genomic efforts in Europe. Dr. Bouzyk’s interests lie in Pharmacogenetics as well as candidate gene and genomic association studies to identify susceptibility genes for both common and rare diseases particularly in the areas of Oncology, Cardiology, Neurological and Psychiatric disorders.

Dr. Bouzyk holds a Ph.D. in Human Molecular Genetics from University of Hertfordshire and a Bachelor of Science with Honors in Biochemistry from University College London.


Emily B. Hollister, PHD

Dr. Emily Hollister is a microbial ecologist with training in bioinformatics and statistics. Dr. Hollister holds a Bachelor’s degree in Biological and Chemical Sciences from Wells College and a Ph.D. in Molecular and Environmental Plant Sciences from Texas A&M University. She also completed her postdoctoral training in Molecular Microbial Ecology in the Department of Soil & Crop Sciences at Texas A&M University.

Prior to joining Diversigen, Dr. Hollister served as an Assistant Professor in the Department of Pathology & Immunology at Baylor College of Medicine and as the Director of Microbial Ecology and Bioinformatics at the Texas Children’s Microbiome Center at Texas Children’s Hospital. Her microbiome experience ranges from soils and biofuel production systems to the human microbiome, built environment, and pre-clinical models of disease.



David Charlot, PhD

Creative bioengineer and business professional with 10 years stellar track record building, testing, and deploying robust systems for the medical research market. I received my Ph.D. in Bioengineering from the University of California, San Diego. For my research, I developed and tested a live cell high content screening platform for drug discovery. I received my B.S. in Physics with Medical Emphasis from Delaware State University.

I am well versed in building complex systems that require data intensive acquisition, statistical analysis, image processing, and hardware control. My strengths include applied biophysics, software engineering, debugging, systems integration, and team leadership.